Loading
A phase 1 trial of Tozuleristide run by Blaze Bioscience Inc., completed.
Study of BLZ-100 in Pediatric Subjects With CNS Tumors is a phase 1 interventional study registered as NCT02462629 by Blaze Bioscience Inc., with 29 participants enrolled, started 2015-06. Conditions recorded: Central Nervous System Tumors. Interventions recorded: BLZ-100.
Shares Tozuleristide, Blaze Bioscience, Brain and spinal cord tumours (all types) and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience, Brain and spinal cord tumours (all types) and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Brain and spinal cord tumours (all types) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/